Skip to main content
. Author manuscript; available in PMC: 2011 May 13.
Published in final edited form as: J Cell Biochem. 2010 May;110(1):171–181. doi: 10.1002/jcb.22523

Fig. 6.

Fig. 6

NF-κB DNA binding activity in nuclear extracts of randomly selected tumor tissues by EMSA in L3.6pl derived tumors (A; upper panel); quantification of NF-κB DNA binding activity (A; lower panel; n = 7). NF-κB DNA binding activity in nuclear extracts of randomly selected tumor tissues by EMSA in COLO-357 derived tumors (B; upper panel), quantification of NF-κB DNA binding activity (B; lower panel), and the inhibition of protein expression of COX-2, EGFR, and pEGFR in COLO-357 derived tumors (C).